Key Quantitative Figures

  • Total Issue Size: ₹29,99,99,870 (Twenty Nine Crores Ninety Nine Lakhs Ninety Nine Thousand Eight Hundred and Seventy Only)
  • Amount Received as of 30th June 2026: ₹7,49,99,968 (25% of total issue size as stipulated subscription amount)
  • Balance Amount Pending: 75% of issue size (₹22,49,99,902) to be received upon warrant conversion
  • Warrant Tenure: 18 months from allotment date

Dates of Action

  • Allotment Date of Fully Convertible Warrants: 27th December 2025
  • Extra Ordinary General Meeting Date: 10th December 2025
  • Notice Date for EGM: 8th November 2025
  • Quarter Ended: 30th June 2026
  • Filing Date: 12th August 2026

Parties Involved

  • Issuing Company: Shree Pushkar Chemicals & Fertilisers Limited
  • Intended Recipient: Madhya Bharat Phosphate Private Limited (Material Wholly Owned Subsidiary)
  • Potential Additional Entity: Kisan Phosphates Private Limited (subject to NCLT approval of amalgamation)
  • Regulatory References: SEBI (ICDR) Regulations, 2018

Purpose and Object of Fund Raise

Funds are intended for investment in Madhya Bharat Phosphate Private Limited in the form of:

  • Equity/Quasi Equity
  • Debt/Loan instruments
  • Inter Corporate Loan/Deposit

These funds will be utilized by the subsidiary as capital expenditure for:

  • Complex Fertilisers
  • Further expansion of unit at Meghnagar, Jhabua, Madhya Pradesh

Regulatory Compliance Status

  • Deviation/Variation: No deviation or variation in use of funds
  • Monitoring Agency: Not Applicable
  • Audit Committee Comments: Nil
  • Auditor Comments: Nil
  • Shareholder Approval: Not Applicable (no deviation)

Special Conditions

A scheme of amalgamation of Madhya Bharat Phosphate Private Limited and Kisan Phosphates Private Limited is pending before Hon'ble National Company Law Tribunal, Mumbai Bench. If approved before utilizing proceeds, the object shall be deemed to include Kisan Phosphates Private Limited.

Financial Impact

As of 30th June 2026, only 25% of the total issue size has been received as subscription amount. The balance 75% will be received as and when warrant holders exercise conversion option to convert fully convertible warrants into equity shares of face value ₹10 each during the 18-month warrant tenure.